Filter
2000
Filtered Results: 2000
Text search:
protocolo
de
diagnóstico
Featured
Recommendations
206
New Publications
432
Language
Document type
No document type
946
Guidelines
458
Studies & Reports
314
Manuals
126
Strategic & Response Plan
99
Fact sheets
25
Training Material
17
Situation Updates
9
Brochures
3
Resource Platforms
3
Countries / Regions
Latin America and the Carribbean
77
Global
73
India
66
Senegal
63
Congo, Democratic Republic of
56
Western and Central Europe
53
Brazil
47
Paraguay
40
Africa
37
Burkina Faso
33
Eastern Europe
33
Kenya
32
Colombia
31
Rwanda
31
Benin
29
South Africa
26
Liberia
25
Haiti
23
Tanzania
23
Sierra Leone
22
Nigeria
21
Mozambique
19
Bolivia
19
Guinea
17
Cameroon
16
Malawi
16
South–East Asia Region
16
Peru
15
Ecuador
15
Zambia
14
Madagascar
14
Ukraine
13
West and Central Africa
13
Eastern Europe and Central Asia
13
Argentina
13
Venezuela
12
Uganda
12
Mali
12
Ghana
11
Chile
11
Côte d’Ivoire / Ivory Coast
11
Togo
10
Namibia
10
Philippines
9
East and Southern Africa
9
Russia
9
El Salvador
8
Syria
8
Central African Republic
8
Ethiopia
8
Angola
8
Nepal
7
Zimbabwe
7
Niger
6
Asia
6
Middle East and North Africa
6
North America
6
Bangladesh
6
Myanmar / Burma
6
Lesotho
5
Germany
5
Honduras
5
Pakistan
5
Guatemala
5
Western Pacific Region
4
France
4
Spain
4
China
3
Albania
3
Congo-Brazzaville
3
Afghanistan
3
Burundi
3
Morocco
3
Cambodia
3
Dominican Republic
3
Sudan
3
Georgia
3
South Sudan
3
Tajikistan
2
Mexico
2
Canada
2
USA
2
Guinea-Bissau
2
Lithuania
2
Gabon
2
Uruguay
2
Tunisia
2
Nicaragua
2
Yemen
2
Chad
2
Indonesia
2
Iraq
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Turkey
1
Iran
1
Estonia
1
Qatar
1
Mauritania
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
Belgium
1
Maldives
1
Portugal
1
Belize
1
Costa Rica
1
Panama
1
Lebanon
1
Moldova
1
Sri Lanka
1
Djibouti
1
Egypt
1
Greece
1
Botswana
1
Eswatini/ Swaziland
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
808
Clinical Guidelines
234
Public Health
128
Women & Child Health
91
Key Resources
70
Pharmacy & Technologies
46
Capacity Building
21
Toolboxes
COVID-19
236
TB
189
NTDs
126
HIV
119
Mental Health
115
Rapid Response
99
AMR
91
Ebola & Marburg
75
Caregiver
48
Malaria
42
NCDs
36
Zika
28
Pharmacy
27
Planetary Health
23
Conflict
22
Disability
18
Refugee
17
Cholera
15
Polio
14
Global Health Education
11
Specific Hazards
9
Natural Hazards
9
Health Financing Toolbox
3
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries
Submitted to the US Agency for International Development by the
Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program.
This manual provides a framework to identify problems and design interventions to improve access to and use of medicines for children. It is a resource for ...
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra...
This study identifies barriers and provides recommendations to improve asthma care in children across sub-Saharan Africa, where qualitative data is lacking despite high rates.
This technical guidance aims to provide guidelines to laboratories and relevant stakeholders in the European Union (EU), European Economic Area (EEA) and other countries in the WHO European region in making decisions on establishing sequencing capacities and capabilities, in making decisions on whic...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities ...
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
Birth defects surveillance: quick reference handbook of selected congenital anomalies and infections
This Quick Reference Handbook of Selected Congenital Anomalies and Infections is a companion tool to Birth defects surveillance: a manual for programme managers, and is intended for use by front-line health care professionals who are diagnosing and collecting data on congenital defects and infection...
Report of a World Health Organization and International Diabetes Federation meeting
The document introduces a simple classification, minimums standards and a registration form for Foreign Medical Teams (FMTs) that may provide surgical and trauma care arriving within the aftermath of a sudden onset disaster. These can serve as tools to improve the coordination of the foreign medical...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting for variations in the benefits and harms of chest im...
Health communication has proven to play a crucial role in addressing diseases such as dengue, Zika and chikungunya, for which there are no definitive or easily accessible vaccines. In this context, this discipline becomes a fundamental tool to promote the change behavior and promote preventive pract...
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to make safer and more effective treatment available to...
